Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cerebral infarction associated with 3,4-methylenedioxymethamphetamine ('Ecstasy') abuse.

Literature DB >> 7628499

Cerebral infarction associated with 3,4-methylenedioxymethamphetamine ('Ecstasy') abuse.

S Hanyu, K Ikeguchi, H Imai, N Imai, M Yoshida.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 1995 PMID： 7628499 DOI： 10.1159/000117117

Source DB: PubMed Journal: Eur Neurol ISSN： 0014-3022 Impact factor: 1.710

Keyword Cloud
Cited

× No keyword cloud information.

9 in total

1. The Netherlands XTC Toxicity (NeXT) study: objectives and methods of a study investigating causality, course, and clinical relevance.

Authors: Maartje M L De Win; Gerry Jager; Hylke K E Vervaeke; Thelma Schilt; Liesbeth Reneman; Jan Booij; Frank C Verhulst; Gerard J Den Heeten; Nick F Ramsey; Dirk J Korf; Wim Van den Brink
Journal: Int J Methods Psychiatr Res Date: 2005 Impact factor: 4.035

2. MDMA ("Ecstasy") and its association with cerebrovascular accidents: preliminary findings.

Authors: L Reneman; J B Habraken; C B Majoie; J Booij; G J den Heeten
Journal: AJNR Am J Neuroradiol Date: 2000 Jun-Jul Impact factor: 3.825

Review 3. Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA; 'ecstasy').

Authors: U D McCann; S O Slate; G A Ricaurte
Journal: Drug Saf Date: 1996-08 Impact factor: 5.606

4. MDMA 'ecstasy' increases cerebral cortical perfusion determined by bolus-tracking arterial spin labelling (btASL) MRI.

Authors: J Rouine; O L Gobbo; M Campbell; V Gigliucci; I Ogden; K McHugh Smith; P Duffy; B Behan; D Byrne; M E Kelly; C W Blau; C M Kerskens; A Harkin
Journal: Br J Pharmacol Date: 2013-07 Impact factor: 8.739

5. Acute methylenedioxymethamphetamine administration: effects on local cerebral blood flow and glucose utilisation in the Dark Agouti rat.

Authors: Linda Quate; Douglas E McBean; Isobel M Ritchie; Henry J Olverman; Paul A T Kelly
Journal: Psychopharmacology (Berl) Date: 2004-02-20 Impact factor: 4.530

Cerebral infarction associated with 3,4-methylenedioxymethamphetamine ('Ecstasy') abuse.

1. The Netherlands XTC Toxicity (NeXT) study: objectives and methods of a study investigating causality, course, and clinical relevance.

2. MDMA ("Ecstasy") and its association with cerebrovascular accidents: preliminary findings.

Review 3. Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA; 'ecstasy').

4. MDMA 'ecstasy' increases cerebral cortical perfusion determined by bolus-tracking arterial spin labelling (btASL) MRI.

5. Acute methylenedioxymethamphetamine administration: effects on local cerebral blood flow and glucose utilisation in the Dark Agouti rat.

6. Dopamine reverses reward insensitivity in apathy following globus pallidus lesions.

Review 7. 3,4-methylenedioxymethamphetamine (MDMA): a review.

8. Epidemic of illicit drug use, mechanisms of action/addiction and stroke as a health hazard.

Review 9. Effect of drug use in the treatment of acute ischemic stroke: A scoping review.